Immunogenicity of therapeutic peptide products: bridging the gaps regarding the role of product-related risk factors
The global market for therapeutic peptides is projected to continue to grow at a fast pace in the coming years in response to high demand for these products. The increasing complexity of chemical and recombinant peptide manufacturing processes may impact product quality attributes, including as rela...
Saved in:
| Main Authors: | Montserrat Puig, Sophie Shubow |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1608401/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic proteins immunogenicity: a peptide point of view
by: Feliciana Real-Fernandez, et al.
Published: (2023-10-01) -
SITA: Predicting site-specific immunogenicity for therapeutic antibodies
by: Yewei Cun, et al.
Published: (2025-06-01) -
Exopeptidase combination enhances the degradation of isotopically labelled gluten immunogenic peptides in humans
by: Sulayman Mourabit, et al.
Published: (2024-10-01) -
Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity Platform
by: Joanna Grudzinska-Goebel, et al.
Published: (2025-05-01) -
Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicity
by: Chitra Upadhyay, et al.
Published: (2024-09-01)